Your browser doesn't support javascript.
loading
Management of Recurrent Retroperitoneal Sarcoma.
Jolissaint, Joshua S; Raut, Chandrajit P; Fairweather, Mark.
Affiliation
  • Jolissaint JS; Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Raut CP; Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Fairweather M; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Curr Oncol ; 30(3): 2761-2769, 2023 02 25.
Article in En | MEDLINE | ID: mdl-36975422
Recurrence after resection of retroperitoneal sarcoma is common and varies by histological subtype. Pattern of recurrence is similarly affected by histology (e.g., well-differentiated liposarcoma is more likely to recur locoregionally, whereas leiomyosarcoma is more likely to develop distant metastases). Radiotherapy may provide effective locoregional control in limited circumstances and the data on the impact of chemotherapy are scant. Surgery for locally recurrent disease is associated with the greatest survival benefit; however, data are retrospective and from a highly selected subgroup of patients. Limited retrospective data have also suggested a survival association with the resection of limited distant metastases. Given the complexity of these patients, multidisciplinary evaluation at a high-volume sarcoma center is critical.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retroperitoneal Neoplasms / Sarcoma / Soft Tissue Neoplasms / Leiomyosarcoma / Liposarcoma Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Curr Oncol Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retroperitoneal Neoplasms / Sarcoma / Soft Tissue Neoplasms / Leiomyosarcoma / Liposarcoma Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Curr Oncol Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza